Page last updated: 2024-08-22
platinum and sc002
platinum has been researched along with sc002 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Appenzeller, C; Bar, J; Cho, BC; Colinet, B; Gottfried, M; Gutierrez, V; Helland, A; Hung, JY; Johnson, ML; Komarnitsky, P; Laktionov, K; Lena, H; Luo, Y; Maag, D; Nickner, C; Okamoto, I; Rich, P; Sun, Z; Vajikova, A; van der Leest, C; Wolf, M; Zvirbule, Z | 1 |
Trials
1 trial(s) available for platinum and sc002
| Article | Year |
|---|---|
Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage-SCLC: Results From the Phase 3 MERU Study.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Benzodiazepinones; Double-Blind Method; Humans; Immunoconjugates; Lung Neoplasms; Middle Aged; Platinum | 2021 |